|
|
Product Name: Atazanavir
Generic Name: Atazanavir
Common Brands: Atazor, Reyataz
Pharmaceutical Categories: HIV, AIDS
Where to buy Atazanavir online:
| Shop | Product | Forms | Strength | Conditions |
| PHARM X SELLER | | Atazor capsules 300 mg | 10% discount coupon: 918cc60b466a42baPayment: PayBis, Cryptocurrency, MG, WU, ZelleShipping: worldwideDelivery: registered airmail, FedEx, DHL |
Atazanavir (trade names include Reyataz, Atavir, Atazor) is an antiviral medication for systemic use from protease inhibitors pharmacological group. This medicine is used for the treatment of HIV/AIDS and for nonoccupational exposure (post-exposure prophylaxis, a preventive medical treatment after a needlestick injury or other potential exposure). It is often indicated in combination with other antiretroviral drugs to treat HIV infection. It works by inhibiting active site of viral protease.
Customers also buy these medications from the same pharmacological classes:
Abacavir (Ziagen)
Abacavir, Lamivudine (Abamune-L, Kivexa)
Amprenavir (Agenerase)
Atazanavir, Cobicistat (Evotaz)
Atazanavir, Ritonavir (Synthivan)
Daclatasvir (Daklinza)
Darunavir (Prezista)
Didanosine (Videx)
Efavirenz (Sustiva)
Fosamprenavir (Lexiva)
Indinavir (Crixivan)
Lamivudine (Epivir, Epivir-HBV)
Lamivudine, Zidovudine (Combivir)
Lopinavir, Ritonavir (Kaletra)
Nelfinavir (Viracept)
Nirmatrelvir, Ritonavir (Paxlovid)
Ritonavir (Norvir)
Saquinavir (Invirase, Fortovase)
Stavudine (Zerit)
Tenofovir Disoproxil (Viread)
Tipranavir (Aptivus)
Zidovudine (Retrovir)
Pharmaceutical and medical classifications:
Anti AIDS drugs
Antiretroviral medications
Antiviral agents
HIV medicines
Viral protease inhibitors
The Anatomical Therapeutic Chemical (ATC) classification system (developed by the World Health Organization):
J - Antiinfectives for systemic use
J05 - Antivirals for systemic use
J05A - Direct acting antivirals
J05AE - Protease inhibitors
J05AE08 - Atazanavir
Medical conditions for atazanavir in the International Statistical Classification of Diseases and Related Health Problems:
Human immunodeficiency virus [HIV] disease - B20
Contact with and (suspected) exposure to communicable diseases - Z20
Contact with and (suspected) exposure to human immunodeficiency virus [HIV] - Z20.6
Pregnancy category:
B2 - Australia
B - United States (No evidence of risk in humans)
Forms of active pharmaceutical ingredients (APIs):
Atazanavir Base
Atazanavir Sulfate
Chemical, international, and other names of this drug:
Atasanafir
Atatsanaviiri
Atazanavir Sulphate
Atazanavirum
Atazanawir
Most known trade names (brands and generics) worldwide:
Ataneil - Mcneil & Argus Pharmaceuticals
Atavir - Cipla
Atazanavir - Aurobindo Pharma, Camber Pharmaceuticals, Hetero Labs, Mepha, Mylan, Teva
Atazor - Emcure Pharmaceuticals
Reyataz - Bristol-Myers Squibb
Other medicines used in combinations with atazanavir:
Cobicistat
Ritonavir
References and external sources:
Atazanavir main article on Wikipedia: https://en.wikipedia.org/wiki/Atazanavir
Atazanavir compound on PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Atazanavir
Atazanavir Sulfate compound on PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Atazanavir-sulfate
Atazanavir medicine on DrugBank: https://go.drugbank.com/drugs/DB01072
Atazanavir Sulfate on DrugBank: https://go.drugbank.com/salts/DBSALT000426
Atazanavir FAQ on MedlinePlus (revised 01/15/2022): https://medlineplus.gov/druginfo/meds/a603019.html
Reyataz (Atazanavir Sulfate) capsules and oral powder drug label on DailyMed (revised September 24, 2020): https://dailymed.nlm.nih.gov/dailymed/drugInfo...
Camber Atazanavir capsules drug label on DailyMed (revised February 2, 2022): https://dailymed.nlm.nih.gov/dailymed/lookup...
Reyataz (Atazanavir Sulfate) capsules for oral use and oral powder official prescribing and patient information, instructions for use from the U.S. FDA (revised 09/2016): https://www.accessdata.fda.gov/drugsatfda_docs/label...
Reyataz (Atazanavir Sulfate) capsules and oral powder prescribing and patient information, instructions for use from Bristol-Myers Squibb pharmaceutical company (revised 09/2020): https://packageinserts.bms.com/pi/pi_reyataz.pdf
Reyataz (Atazanavir Sulfate) 150, 200 and 300 mg capsules product monograph from Bristol-Myers Squibb (revised April 28, 2020): https://www.bms.com/assets/bms/ca/documents/...
Atazor (Atazanavir Sulfate) capsules 150 mg, 200 mg, 300 mg patient information leaflet from Activo Health (revised 30 September 2016): https://activo.co.za/downloads/local/pi/Atazor-PI.pdf
Reyataz (Atazanavir) 300 mg hard capsules package information leaflet for users on Medicines.org.uk (revised August 2020): https://www.medicines.org.uk/emc/files/pil.7738.pdf
Revised: December 2022
|
Disclaimer: Please note, this website is not an online pharmacy, drugstore and related online pharma shop. It does not sell, supply or advertise any prescription and OTC drugs, medications, other goods and services. All reviews, links, lists, databases, texts, videos, images, and other content on the website are provided free and only for informational and educational purposes. Medical content on this website, including drug names, indications, contraindication, side effects, categories, classifications, forms, doses, prices, other health and pharmaceutical information are taken only from trusted and authoritative professional sources (see "References"), reviewed and prepared by our licensed experts, content inspectors and editors.
You should always consult your doctor or other healthcare professional before using any medication. This website, our staff and support do not provide own medical instructions and advices.
All brands and trade names appearing on the website are registered trademarks and intellectual property of their respective companies.
Remember that buying drugs and medicines online is a responsibility only of customers, sellers and suppliers regarding existing legislation in their jurisdictions.
|
|